UK Device Fees Uplift Next Year As MHRA Begins Consultation
Agency sets long-term goal of self sufficiency
Executive Summary
UK device industry stakeholders will have until 23 November to respond to the UK MHRA’s newly-proposed fee increases, which the agency says will enable it to secure full cost recovery of the services it provides.
You may also be interested in...
UK MHRA Notes Concern Over Medtech’s Mid-2023 Deadline – But Still No Draft Law Progress
The One Agency initiative, patient safety, methods of funding and recruitment needs were pressing discussion themes during the MHRA’s April 2022 board meeting held in public.
MHRA Chairman Lightfoot Ready To Lead Post-EU Agenda For UK Devices
The UK devices regulator will prioritize innovation, global best practice and enhanced patient safety and the patient voice, MHRA board chairman Stephen Lightfoot said during the ABHI’s spring regulatory conference. New fees for industry are also on the cards.
The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’
The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.